Two-week wearable heart monitor after unexplained fainting improves detection of life-threatening conditions
Source Summary
A trial presented at the European Society of Cardiology Congress in Munich found that fitting patients with a wearable heart monitor for 14 days after presenting to the emergency room with unexplained fainting improves detection of life-threatening heart conditions. The study demonstrates the clinical value of extended cardiac monitoring in this patient population.
Why it matters
Early detection of life-threatening heart conditions in patients with unexplained fainting can prevent serious complications and guide appropriate treatment decisions.



